Connect Biopharma Holdings Ltd ADR (CNTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 16 | 48 | 0 | 698 | 1,219 |
| Gross Profit | 16 | 48 | N/A | 698 | 1,219 |
| Operating Expenses | 17,693 | 13,472 | 11,447 | 4,081 | 15,065 |
| Operating Income | -17,677 | -13,424 | -11,447 | -3,383 | -13,846 |
| Other Income | 538 | 580 | 1,229 | -5,417 | 1,027 |
| Pre-tax Income | -17,139 | -12,844 | -10,218 | -8,800 | -12,819 |
| Income Tax | 61 | 55 | 54 | 106 | 57 |
| Net Income Continuous | -17,200 | -12,899 | -10,272 | -8,906 | -12,876 |
| Net Income | $-17,200 | $-12,899 | $-10,272 | $-8,906 | $-12,876 |
| EPS Basic Total Ops | -0.31 | -0.23 | -0.19 | N/A | -0.23 |
| EPS Basic Continuous Ops | -0.31 | -0.23 | -0.19 | N/A | -0.23 |
| EPS Diluted Total Ops | -0.31 | -0.23 | -0.19 | N/A | -0.23 |
| EPS Diluted Continuous Ops | -0.31 | -0.23 | -0.19 | N/A | -0.23 |
| EPS Diluted Before Non-Recurring Items | -0.31 | -0.23 | -0.19 | N/A | N/A |
| EBITDA(a) | $-17,498 | $-13,253 | $-11,274 | $-3,225 | $-13,670 |